Company: GRCE
Filing Date: 2025-03-10
Form Type: S-3
Source: 0001140361-25-007769
Chunk: 3

Company: Grace Therapeutics, Inc.
Filing Date: 2025-03-10
Form: S-3
Chunk 3
---
ING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK.
          SEE THE SECTION ENTITLED “RISK FACTORS” BEGINNING ON PAGE**

#### 4
**OF THIS PROSPECTUS AND UNDER SIMILAR HEADINGS IN THE DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS.

Neither the Securities and Exchange Commission nor any state
          or other securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.**

<div align='center'>The date of this prospectus is     , 2025</div>

TABLE OF CONTENTS

TABLE OF CONTENTS

|                                                   |     | Page |
| ABOUT THIS PROSPECTUS                             |     |   ii |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS |     |  iii |
| PROSPECTUS SUMMARY                                |     |    1 |
| THE OFFERING                                      |     |    3 |
| RISK FACTORS                                      |     |    4 |
| USE OF PROCEEDS                                   |     |    5 |
| SELLING STOCKHOLDERS                              |     |    6 |
| PLAN OF DISTRIBUTION                              |     |    9 |
| LEGAL MATTERS                                     |     |   11 |
| EXPERTS                                           |     |   11 |
| INCORPORATION BY REFERENCE                        |     |   12 |
| WHERE YOU CAN FIND MORE INFORMATION               |     |   12 |

i

#### TABLE OF CONTENTS

### ABOUT THIS PROSPECTUS
**This prospectus relates to the resale, from time to time, by the selling
          stockholders named in this prospectus under the section entitled “Selling Stockholders”, of up to 8,836,584 shares of Common Stock, which are comprised of (i) the Shares and (ii) the Warrant Shares issuable upon the exercise of either the
          Pre-Funded Warrants or the Warrants.

We are registering the offer and resale of the Shares and Warrant Shares to
          satisfy the provisions of the Registration Rights Agreement, in connection with the Private Placement Offering, pursuant to the Securities Purchase Agreements.

We are not selling any shares of Common Stock under this prospectus and will not
          receive any of the proceeds from the sale of the Shares and Warrant Shares by the Selling